In MMR-deficient tumors, reduced β-catenin expression in tumor buds was demonstrated in comparison to MMR-proficient tumors (21), leading to the speculation that mechanisms other than only Wnt signaling may lead to the formation of tumor buds in MMR-deficient cancers. This evidence concerns the gene MRC1 and cancer.